The PrEP Access Act would expand Medicare coverage to include HIV prevention services provided by pharmacists, starting January 1, 2027. Currently, Medicare only covers these services when delivered by physicians; this bill allows pharmacists to provide and bill for related services including pre-exposure prophylaxis (PrEP), post-exposure prophylaxis, medication administration, screenings, counseling, and related laboratory tests—as long as they are legally authorized to do so under state law. Medicare would cover 80 percent of the cost for these pharmacist-provided services, and pharmacists would be prohibited from balance billing patients for amounts above Medicare's approved payment rates. The bill affects Medicare beneficiaries seeking HIV prevention services and expands access by leveraging pharmacists' existing community presence, though it does not specify new federal funding allocations.